1. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling. (June 2015) Authors: Yakirevich, Evgeny; Ali, Siraj M.; Mega, Anthony; McMahon, Caitlin; Brodsky, Alexander S.; Ross, Jeffrey S.; Allen, Justin; Elvin, Julia A.; Safran, Howard; Resnick, Murray B. Journal: American journal of surgical pathology Issue: Volume 39:Number 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling. (June 2015) Authors: Yakirevich, Evgeny; Ali, Siraj M.; Mega, Anthony; McMahon, Caitlin; Brodsky, Alexander S.; Ross, Jeffrey S.; Allen, Justin; Elvin, Julia A.; Safran, Howard; Resnick, Murray B. Journal: American journal of surgical pathology Issue: Volume 39:Number 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Issue 10 (3rd March 2015) Authors: Tomimaru, Yoshito; Mishra, Sasmita; Safran, Howard; Charpentier, Kevin P.; Martin, William; De Groot, Anne S.; Gregory, Stephen H.; Wands, Jack R. Journal: Vaccine Issue: Volume 33:Issue 10(2015) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. Issue 1 (4th February 2019) Authors: Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R.; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B.; Xiong, Hui... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma. Issue 1 (31st December 2022) Authors: Hsu, Andrew; Huntington, Kelsey E.; De Souza, Andre; Zhou, Lanlan; Olszewski, Adam J.; Makwana, Nirav P.; Treaba, Diana O.; Cavalcante, Ludimila; Giles, Francis J.; Safran, Howard; El-Deiry, Wafik S.; Carneiro, Benedito A. Journal: Cancer biology & therapy Issue: Volume 23:Issue 1(2022) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CMET-14. BRAIN METASTASES: A NEW PATHOPHYSIOLOGY, A NEW TREATMENT PARADIGM, AND, PERHAPS, A NEW PROGNOSIS. (11th November 2019) Authors: Dowd, Richard; Ouyang, Tao; Thamburaj, Krishnamoorthy; Aregawi, Dawit; Safran, Howard; Zacharia, Brad; Glantz, Michael Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivo. Issue 10 (2nd December 2021) Authors: Jhaveri, Aakash V.; Zhou, Lanlan; Ralff, Marie D.; Lee, Young S.; Navaraj, Arunasalam; Carneiro, Benedito A.; Safran, Howard; Prabhu, Varun V.; Ross, Eric A.; Lee, Seulki; El-Deiry, Wafik S. Journal: Cancer biology & therapy Issue: Volume 22:Issue 10/12(2021) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-13. MALIGNANT GLIOMA SUBSET FROM ACTUATE 1801 PHASE 1/2 STUDY OF 9-ING-41, A GLYCOGEN SYNTHASE KINASE 3 BETA (GSK-3β) INHIBITOR, AS A SINGLE AGENT AND COMBINED WITH CHEMOTHERAPY REFRACTORY. (12th November 2021) Authors: Odia, Yazmin; Cavalcante, Ludimila; Safran, Howard; Powell, Steven Francis; Munster, Pamela; Ma, Wen Wee; Carneiro, Benedito; Bastos, Bruno; Giles, Francis; Sahebjam, Solmaz Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors. (16th March 2016) Authors: Olszanski, Anthony J.; Smith, David C.; Camacho, Luis H.; Thompson, John; Ramalingam, Suresh S.; Harvey, R. Donald; Campos, Luis; Ferry, David; Tang, Shande; Gao, Ling; Safran, Howard Journal: Oncologist Issue: Volume 21:Number 4(2016) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I study. (28th August 2014) Authors: Winer, Eric S.; Safran, Howard; Karaszewska, Boguslawa; Richards, Donald A.; Hartner, Lee; Forget, Frederic; Ramlau, Rodryg; Kumar, Kirushna; Mayer, Bhabita; Johnson, Brendan M.; Messam, Conrad A.; Mostafa Kamel, Yasser Journal: Cancer medicine Issue: Volume 4:Number 1(2015:Jan.) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗